JDOC vs TRUT

JDOCCJPMorgan Healthcare Leaders ETF

TRUTBVanEck Technology TruSector ETF

In short

JDOC Most healthcare ETFs just buy the sector list. JDOC is the stock-picker's version: about 60 names chosen by J.P. Morgan healthcare specialists hunting companies whose future growth the market underrates, with the whole globe in bounds.

TRUT Diversification rules force most tech ETFs to trim their biggest names. TRUT's answer: own the giants directly up to the legal line, then top up with sector ETFs so the portfolio mirrors the sector's real shape.

Stated mandate

JDOC Seeks long-term capital appreciation by investing primarily in healthcare companies that the adviser considers leaders, particularly where future growth is underappreciated by the market.

TRUT The Fund seeks long-term capital appreciation through active investment in securities of information technology-related companies or instruments providing exposure to them.

Why people hold it

• JDOC Concentrated by design: about 60 healthcare stocks rather than the full sector roster, so the managers' picks actually shape the portfolio.jpmorgan.com
• The mandate is global, so European and Asian drugmakers and device firms are as eligible as US-listed ones.jpmorgan.com
• Run by J.P. Morgan portfolio managers who specialize in healthcare inside its equity research groups, leaning on the firm's global bench of sector analysts.sec.govjpmorgan.com
• 0.65% a year for specialist active research sits right at the median fee for actively managed US equity ETFs, not a markup for the J.P. Morgan name.

• TRUT The mechanism is the point. Fund rules cap one stock at 25% and stocks above 5% at 50% combined; TRUT fills the gap with targeted sector ETFs instead of overweighting smaller names.vaneck.comvaneck.com 2
• 0.14% a year for an actively managed fund, against a median near 0.65% across active US equity peers. Cheap enough to sit alongside index products.
• One of the two originals in VanEck's TruSector line, launched in 2025. The approach has since been extended across all 11 GICS sectors.vaneck.comvaneck.com 2
• About 80 positions, quarterly distributions, and steady day-to-day trading. On cost and tradability it lands in the upper tier of its active US equity cohort.

Worth knowing

• JDOC A small fund that trades thinly since its 2023 launch, so spreads can run wider than on the giant healthcare index ETFs and execution matters more.
• One sector, roughly 60 names. Drug pricing rules, patent cliffs and trial outcomes land harder here than in a diversified fund.prnewswire.com
• Broad active core rivals like DFAC and AVLC charge under 0.2% for far wider portfolios. JDOC's fee reflects a narrow specialist mandate, not a core holding's price.

• TRUT Part of the exposure arrives through other ETFs rather than shares the fund holds outright. That is the workaround that makes uncapped weights possible, and it adds a layer.vaneck.com
• Uncapped means concentrated. Leaning fully into tech's largest companies ties results to a handful of mega-caps more tightly than a capped sector fund would.vaneck.com
• Launched August 2025, so there is only a short record of how closely the hybrid build actually shadows an uncapped tech benchmark.

Full JDOC profile⁠

Full TRUT profile⁠